S
Samchundang Pharm. Co., Ltd.
Profile managed by Bizz Id
Corea
250-499
1943
Description
Leading Korean pharmaceutical company specializing in ophthalmic products (60% of revenue). Develops high-quality generics and biosimilars with US and EU GMP certifications. Flagship biosimilar SCD411 (aflibercept) approved in Canada, EU, Korea, and Japan.